期刊
CLEVELAND CLINIC JOURNAL OF MEDICINE
卷 70, 期 6, 页码 553-560出版社
CLEVELAND CLINIC
DOI: 10.3949/ccjm.70.6.553
关键词
-
Treating patients with isolated low high-density lipoprotein cholesterol (HDL-C) remains daunting. The decision to treat depends on the individual patient's overall risk for coronary heart disease (CHD). Strategies for raising HDL-C levels can include various lifestyle and drug therapies, which should be tailored to individual patients. While no current therapy is optimal, many can yield modest increases that translate into reduced risk for CHD events.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据